Top Healthcare companies in United States by EBITDA Margin

This ranking features the top 470 Healthcare companies in United States ranked by EBITDA Margin, averaging a EBITDA Margin of -7,500.38%, for February 04, 2025.

United States

Healthcare

#	Name	EBITDA Margin	Reported Date	Stock Price	Change	Country
1	Inhibrx Biosciences, Inc. 1 INBX	95,478.43%	Sept. 30, 2024	USD 12.72	-6.33%	United States
2	Maravai LifeSciences Holdings, Inc. 2 MRVI	198.02%	Sept. 30, 2024	USD 4.94	0.20%	United States
3	Royalty Pharma plc 3 RPRX	76.29%	Dec. 31, 2023	USD 31.33	-0.79%	United States
4	SIGA Technologies, Inc. 4 SIGA	60.43%	Sept. 30, 2024	USD 5.78	-3.34%	United States
5	Halozyme Therapeutics, Inc. 5 HALO	60.22%	Sept. 30, 2024	USD 56.28	-0.64%	United States
6	Collegium Pharmaceutical, Inc. 6 COLL	57.86%	Sept. 30, 2024	USD 31.20	-2.86%	United States
7	United Therapeutics Corporation 7 UTHR	54.69%	Sept. 30, 2024	USD 354.58	0.97%	United States
8	Protagonist Therapeutics, Inc. 8 PTGX	46.76%	Sept. 30, 2024	USD 37.20	-1.59%	United States
9	American Shared Hospital Services 9 AMS	44.11%	Sept. 30, 2024	USD 3.15	2.27%	United States
10	AbbVie Inc. 10 ABBV	43.66%	Sept. 30, 2024	USD 190.14	3.39%	United States
11	Lantheus Holdings, Inc. 11 LNTH	43.57%	Sept. 30, 2024	USD 89.54	-3.21%	United States
12	Catalyst Pharmaceuticals, Inc. 12 CPRX	41.81%	Sept. 30, 2024	USD 22.62	0.27%	United States
13	Doximity, Inc. 13 DOCS	41.08%	Sept. 30, 2024	USD 59.10	NA	United States
14	Utah Medical Products, Inc. 14 UTMD	40.80%	Sept. 30, 2024	USD 59.92	-2.14%	United States
15	Amgen Inc. 15 AMGN	40.24%	Sept. 30, 2024	USD 288.87	1.21%	United States
16	Roper Technologies, Inc. 16 ROP	37.46%	Dec. 31, 2024	USD 577.04	0.24%	United States
17	Amphastar Pharmaceuticals, Inc. 17 AMPH	37.15%	Sept. 30, 2024	USD 33.39	-4.24%	United States
18	Waters Corporation 18 WAT	35.89%	Sept. 28, 2024	USD 411.19	-1.03%	United States
19	Regeneron Pharmaceuticals, Inc. 19 REGN	34.89%	Sept. 30, 2024	USD 666.85	-0.91%	United States
20	RadNet, Inc. 20 RDNT	34.45%	Sept. 30, 2024	USD 66.60	1.73%	United States
21	Semler Scientific, Inc. 21 SMLR	34.29%	Sept. 30, 2024	USD 50.46	-2.89%	United States
22	Johnson & Johnson 22 JNJ	33.65%	Sept. 29, 2024	USD 151.87	-0.18%	United States
23	ResMed Inc. 23 RMD	33.62%	Dec. 31, 2024	USD 240.55	1.85%	United States
24	Zimmer Biomet Holdings, Inc. 24 ZBH	33.04%	Sept. 30, 2024	USD 108.16	-1.21%	United States
25	Hologic, Inc. 25 HOLX	32.16%	Sept. 28, 2024	USD 71.72	-0.58%	United States
26	IRadimed Corporation 26 IRMD	31.94%	Sept. 30, 2024	USD 59.35	0.24%	United States
27	Intuitive Surgical, Inc. 27 ISRG	31.84%	Sept. 30, 2024	USD 578.55	1.17%	United States
28	Biogen Inc. 28 BIIB	30.78%	Sept. 30, 2024	USD 142.34	-1.10%	United States
29	Green Thumb Industries Inc. 29 GTII.CN	30.74%	Dec. 31, 2023	USD 6.89	-1.61%	United States
30	Eli Lilly and Company 30 LLY	30.62%	Sept. 30, 2024	USD 810.43	-0.08%	United States
31	Exelixis, Inc. 31 EXEL	30.55%	Sept. 27, 2024	USD 32.88	-0.81%	United States
32	European Wax Center, Inc. 32 EWCZ	30.33%	Oct. 5, 2024	USD 6.70	-0.74%	United States
33	Merck & Co., Inc. 33 MRK	30.33%	Sept. 30, 2024	USD 99.79	0.98%	United States
34	National Research Corporation 34 NRC	30.04%	Sept. 30, 2024	USD 16.36	-1.86%	United States
35	Harmony Biosciences Holdings, Inc. 35 HRMY	29.97%	Sept. 30, 2024	USD 38.70	-0.18%	United States
36	Bio-Techne Corporation 36 TECH	29.69%	Sept. 30, 2024	USD 72.05	-2.04%	United States
37	Fortive Corporation 37 FTV	29.56%	Sept. 27, 2024	USD 80.24	-1.34%	United States
38	Edwards Lifesciences Corporation 38 EW	28.99%	Sept. 30, 2024	USD 71.38	-1.48%	United States
39	LeMaitre Vascular, Inc. 39 LMAT	28.33%	Sept. 30, 2024	USD 95.43	-1.55%	United States
40	Danaher Corporation 40 DHR	28.28%	Dec. 31, 2024	USD 214.26	-3.81%	United States
41	Ironwood Pharmaceuticals, Inc. 41 IRWD	28.05%	Sept. 30, 2024	USD 2.10	-10.47%	United States
42	Innoviva, Inc. 42 INVA	27.94%	Sept. 30, 2024	USD 18.41	-1.23%	United States
43	Entrada Therapeutics, Inc. 43 TRDA	27.62%	Sept. 30, 2024	USD 13.33	-0.82%	United States
44	Neurocrine Biosciences, Inc. 44 NBIX	27.38%	Sept. 30, 2024	USD 150.10	-1.13%	United States
45	Revvity, Inc. 45 RVTY	27.25%	Dec. 29, 2024	USD 123.69	-1.93%	United States
46	Agilent Technologies, Inc. 46 A	26.62%	Oct. 31, 2024	USD 148.63	-1.91%	United States
47	Krystal Biotech, Inc. 47 KRYS	26.50%	Sept. 30, 2024	USD 159.03	-0.44%	United States
48	Organon & Co. 48 OGN	26.32%	Sept. 30, 2024	USD 14.91	-4.18%	United States
49	Abbott Laboratories 49 ABT	26.09%	Sept. 30, 2024	USD 128.45	0.41%	United States
50	West Pharmaceutical Services, Inc. 50 WST	25.86%	Sept. 30, 2024	USD 337.03	-1.32%	United States

1 2 3 4 … 10

Frequently Asked Questions

Which Healthcare company in United States has the highest EBITDA Margin ?

The Healthcare company in United States with the highest EBITDA Margin is Inhibrx Biosciences, Inc. (NasdaqGS: INBX) at 95,478.43%.
Which Healthcare company in United States has the lowest EBITDA Margin ?

The Healthcare company in United States with the lowest EBITDA Margin is Inhibikase Therapeutics, Inc. (NasdaqCM: IKT) at -2,003,766,400.00%.

What are the top 10 Healthcare companies in United States by EBITDA Margin ?

The top 10 Healthcare companies in United States by EBITDA Margin are Inhibrx Biosciences, Inc., Maravai LifeSciences Holdings, Inc., Royalty Pharma plc, SIGA Technologies, Inc., Halozyme Therapeutics, Inc., Collegium Pharmaceutical, Inc., United Therapeutics Corporation, Protagonist Therapeutics, Inc., American Shared Hospital Services and AbbVie Inc..
What are the bottom 10 Healthcare companies in United States by EBITDA Margin ?

The bottom 10 Healthcare companies in United States by EBITDA Margin are Inhibikase Therapeutics, Inc., Immix Biopharma, Inc., Bullfrog AI Holdings, Inc. Common Stock, Benitec Biopharma Inc., Greenwich LifeSciences, Inc., Acelyrin, Inc., Altimmune, Inc., Allogene Therapeutics, Inc., 89bio, Inc. and Revolution Medicines, Inc..

Frequently Asked Questions

Don’t Miss A Beat